Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia

Myeloid Leukemia ◽

Residual Disease ◽

Epigenetic Therapy ◽

Core Binding Factor ◽

Disease Eradication ◽

Binding Factor ◽

Minimal Residual ◽

Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact ofC-KIT,FLT3, andJAK2mutations on clinical outcome

Leukemia & Lymphoma ◽

10.1080/10428190903085951 ◽

2009 ◽

Vol 50 (9) ◽

pp. 1448-1460 ◽

Cited By ~ 24

Author(s):

Jana Marková ◽

Zuzana Trnková ◽

Petra Michková ◽

Jacqueline Maaloufová ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Outcome ◽

Myeloid Leukemia ◽

Residual Disease ◽

Core Binding Factor ◽

Binding Factor ◽

The Impact ◽

Minimal Residual ◽

Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease

European Journal Of Haematology ◽

10.1111/ejh.12130 ◽

2013 ◽

Vol 91 (3) ◽

pp. 209-218 ◽

Cited By ~ 28

Author(s):

Montserrat Hoyos ◽

Josep F. Nomdedeu ◽

Jordi Esteve ◽

Rafael Duarte ◽

Josep M. Ribera ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Leukocyte Count ◽

Core Binding Factor ◽

Binding Factor ◽

The Impact ◽

Minimal Residual ◽

Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center

Annals of Hematology ◽

10.1007/s00277-021-04432-z ◽

2021 ◽

Author(s):

Wenbing Duan ◽

Xiaohong Liu ◽

Xiaosu Zhao ◽

Jinsong Jia ◽

Jing Wang ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Single Center ◽

Core Binding Factor ◽

Kit Mutation ◽

Clinical Cohort ◽

Binding Factor ◽

Minimal Residual ◽

Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1–RUNX1T1

Experimental Hematology ◽

10.1016/j.exphem.2021.01.007 ◽

2021 ◽

Author(s):

Hui Wei ◽

Xueou Liu ◽

Ying Wang ◽

Dong Lin ◽

Chunlin Zhou ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Application ◽

Myeloid Leukemia ◽

Residual Disease ◽

Minimal Residual ◽

Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia

Translational Oncology ◽

10.1016/j.tranon.2021.101119 ◽

2021 ◽

Vol 14 (8) ◽

pp. 101119

Author(s):

Xiaoyan Chen ◽

Suyu Zong ◽

Meihui Yi ◽

Chao Liu ◽

Bingrui Wang ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Minimal Residual Disease Monitoring ◽

Childhood Acute Myeloid Leukemia ◽

Minimal Residual ◽

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia

Blood Cancer Journal ◽

10.1038/s41408-021-00461-z ◽

2021 ◽

Vol 11 (4) ◽

Author(s):

Ya-Zhen Qin ◽

Qian Jiang ◽

Yu Wang ◽

Hao Jiang ◽

Lan-Ping Xu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Kit Mutation ◽

The Impact ◽

Minimal Residual ◽

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

Haematologica ◽

10.3324/haematol.2016.159343 ◽

2017 ◽

Vol 102 (5) ◽

pp. 865-873 ◽

Cited By ~ 79

Author(s):

Sarah A. Buckley ◽

Brent L. Wood ◽

Megan Othus ◽

Christopher S. Hourigan ◽

Celalettin Ustun ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Cell Transplantation ◽

Residual Disease ◽

Meta Analysis ◽

Hematopoietic Cell ◽

Minimal Residual ◽

Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia

Cancer ◽

10.1002/cncr.30361 ◽

2016 ◽

Vol 123 (3) ◽

pp. 426-435 ◽

Cited By ~ 28

Author(s):

Farhad Ravandi ◽

Jeffrey Jorgensen ◽

Gautam Borthakur ◽

Elias Jabbour ◽

Tapan Kadia ◽

...

Keyword(s):

Flow Cytometry ◽

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Multiparameter Flow Cytometry ◽

Younger Patients ◽

Minimal Residual ◽

The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations

Hematology ◽

10.1080/16078454.2021.1880753 ◽

2021 ◽

Vol 26 (1) ◽

pp. 179-185

Author(s):

Wen-shuai Zheng ◽

Ya-lei Hu ◽

Li-xun Guan ◽

Bo Peng ◽

Shen-yu Wang

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Intermediate Risk ◽

Cebpa Mutations ◽

Minimal Residual ◽

Monitoring of minimal residual disease in acute myeloid leukemia

Current Opinion in Oncology ◽

10.1097/cco.0b013e3283311856 ◽

2009 ◽

Vol 21 (6) ◽

pp. 582-588 ◽

Cited By ~ 21

Author(s):

Francesco Buccisano ◽

Luca Maurillo ◽

Alessandra Spagnoli ◽

Maria Ilaria Del Principe ◽

Eleonora Ceresoli ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Minimal Residual ◽